GoodRx reports that GLP-1 medications, while not FDA-approved for high blood pressure, can aid in lowering it through weight loss and heart health benefits.

GLP-1 injections, which are used for weight loss, cost around $500 a month.

Doctronic reports that Foundayo, an oral GLP-1 for diabetes, shows promise but lacks long-term safety data beyond 68 weeks; ongoing studies are needed.

GoodRx reports that Foundayo, a new oral weight-loss pill, is FDA-approved for obesity treatment, offering an alternative to injections with effective results.

Doctronic reports new AI analysis reveals GLP-1 medications may cause underreported symptoms like menstrual irregularities and fatigue.

GoodRx reports that GLP-1 medications aid weight loss but often require long-term use to maintain results and prevent weight regain.

The thriving market in online, counterfeit GLP-1 drugs that do not meet FDA criteria poses serious risks to consumers.

LifeStance Health reports GLP-1 medications, known for weight loss, may also enhance mental health by improving mood, reducing cravings, and aiding emotional regulation.

Ivim Health reports that peptide therapies, spurred by GLP-1 interest, require careful understanding and medical oversight for safe use.

Understood reports GLP-1 drugs like Ozempic may improve ADHD symptoms by quieting food thoughts, but more research is needed for direct effects.